News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Judge Orders Guidant Corporation To Pay $296 Million Fine For Withholding Information About Faulty Heart Devices
January 13, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KHN -- This Boston Scientific Corp. subsidiary faces this fine as well as three years of probation as part of a case that began in 2005.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Rare diseases
Senator Ron Johnson Launches Investigation Into FDA Rare Disease Rejections
March 10, 2026
·
3 min read
·
Heather McKenzie
Opinion
Direct-to-Consumer Drugs Are Not a Panacea for High Costs
March 6, 2026
·
4 min read
·
Michael Grosberg
Patents
Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant
March 4, 2026
·
2 min read
·
Tristan Manalac
Opinion
Navigating the FDA After the Storm To Advance Drug Candidates
March 3, 2026
·
4 min read
·
John Kirk
